Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
6m agoHovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
6m agoLivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
6m agoKKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion
7m agoCosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
7m agoIntuitive Announces Innovations to Advance Quintuple Aim
Royalty Pharma Plc logo

Royalty Pharma Plc

About

53.06USD+0.65 +1.24%
Closed • Updated at 13:22 GMT+00:00
Market Cap$30.56B
P/E Ratio27.79
Volume2.87M
Beta0.51
RSI67.78
Health TechnologyPharmaceuticals: Major

Royalty Pharma Plc — investor relations, events, news, and company updates on 6ix.

Latest News

May 7 2026
Royalty Pharma to present at upcoming investor conferences
May 6 2026
Royalty Pharma reports first quarter 2026 results
Apr 21 2026
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
Apr 17 2026
Royalty Pharma Declares Second Quarter 2026 Dividend
Apr 15 2026
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026

Community Chat

Ask AI

6ix6ixAIEvents